Date: December 15-16 2021
Online Livestream
On December 15-16, 2021, pharma companies, medical vendors, and clinicians are invited to attend the 5th Virtual Clinical Trials conference, the industry’s most trusted and long-lasting conference on clinical trials. The event is hosted by Dynamic Global Events (“DGE”), a Life Science Leader in organizing B2B Events.
As clinical trials are switching to more decentralized and hybrid models, a collaborative platform for the exchange of information is vital to keep up with the rapid growth. At the 5th Virtual Clinical Trials Conference, hear from those on the front lines of these remote applications and discuss the future of clinical trials from leading pharma industry stalwarts. At this 2-day event, attendees can learn how to successfully conduct clinal trial operating procedures and protocol design and learn what major obstacles to avoid in data compliance.
The speaking faculty consists of an eminent panel of dignitaries and pharma industry professional experts who will offer all-new insights on constructing and measuring endpoints, executing effective patient recruitment strategies, applying innovative technologies, and many other insightful strategies to ensure your next clinical trial is a success. Clinicians, trial managers, clinical data experts, vendors, pharma companies, and scientists should leverage the opportunity offered by the conference.
Important topics of discussion include:
- Implement robust trial design techniques and SOPs to improve your internal processes
- Improve patient enrollment, safety monitoring, and follow up outcomes
- Enhance approaches to flexible protocol design in DCTs
- Increase collaboration measures to ensure quality in your decentralized approach
- Understand new and exciting technologies that will increase efficiencies in your trials
Adapt your organization to the virtual change at this 2-day event which will commence in a virtual setting from 8:30 am on 15th December. Attendees will hear how clinical trials are conducted in the European Union (“EU”) and the major changes clinical trials are facing around the globe. Other topics that will be discussed include standardizing safety operating procedures, understanding ways to eliminate duplicate data entry, and how eConsent helps with studies at the site, sponsor, and CROs level to achieve success.
For more information, please visit https://nnw.fm/XKgfX.
About NetworkNewsWire
NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit https://www.networknewswire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.networknewswire.com
212.418.1217 Office
[email protected]
NetworkNewsWire is part of the InvestorBrandNetwork.
